Citius Oncology, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | – | – | -4,446.6% | |
| – | – | +281.5% | +11.0% | |
| – | +541.0% | +3,105.8% | -25.1% | |
| – | – | +0.0% | +0.0% | |
| – | -98.0% | +278.8% | +15.0% | |
| – | – | – | -100.0% | |
| – | -97.5% | +192.7% | +211.2% | |
| – | -188.7% | – | – | |
| – | – | – | -4,446.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.